PTK2 and prostate cancer: In a recent study, we could show that positivity of Thrombospondin Type-1 Domain-Containing 7A (THSD7A) is associated with a high expression of Focal Adhesion Kinase (FAK) and with adverse clinicopathological parameters in prostate cancer [5].